New Fed Chair Kevin Warsh Just Delivered 29 Words on AI. 2 Dividend Stocks That Are Well Positioned to Thrive in This Changing Landscape.

The article highlights IBM and Accenture as cheap AI stocks with attractive dividends, citing IBM's 2.71% yield and 26 straight years of dividend increases, and Accenture's 5.1% yield with 15 consecutive years of raises. IBM is described as trading at 22x earnings and 20x forward earnings, while Accenture trades at 10x earnings and 8x forward earnings, with Wall Street's $180 price target implying 47% upside. The piece is broadly supportive of both names, though it also warns that AI valuations remain elevated and could face a pullback.

Analysis

The key market takeaway is not that IBM and ACN are “cheap,” but that they are being re-rated from long-duration AI beneficiaries into cash-flow defensives with AI optionality. That matters because in a valuation reset, the market usually stops paying for narrative acceleration and starts paying for visible capital returns; both names can attract incremental ownership from income mandates and low-volatility allocators that previously ignored AI exposure.

Second-order, this creates a relative-value wedge versus the higher-multiple AI complex: enterprises still need implementation, integration, and governance layers even if model spend normalizes. IBM and ACN sit closer to the monetization bottleneck than the model builders, so a slower AI capex cycle can actually improve their mix as clients shift from experimentation to procurement and deployment. The risk is that consulting demand is a late-cycle indicator; if corporate IT budgets roll over, ACN’s revenue elasticity can turn negative faster than the market expects.

The bigger contrarian point is that the yield appeal may be masking different quality profiles. IBM’s return case is more reliant on multiple stabilization and margin discipline, while ACN has the cleaner secular franchise but is now pricing in a growth recession. That asymmetry suggests ACN is the better tactical rebound, but IBM may offer the better downside capture if rates stay elevated and investors keep favoring current cash returns over distant AI upside.

Key Decisions for Investors

• Long ACN / short a high-multiple AI basket (or NVDA on a beta-adjusted basis) for 3-6 months: expresses a valuation mean-reversion trade with a dividend cushion and lower business-model risk than pure AI infra names.
• Buy IBM on weakness with a 6-12 month horizon: target a re-rating from distressed-tech to income compounder; downside is capped by yield support, while any stabilization in AI software spending can expand the multiple modestly.
• Sell put spreads in ACN 2-4 months out at strikes below current price to monetize elevated implied volatility after the selloff; structure for limited premium capture with defined risk if guidance deteriorates again.
• If you want cleaner upside convexity, pair long ACN against short software/services peers that lack dividends: the market is likely to reward balance-sheet quality and return of capital before it pays for uncertain AI acceleration.
• Do not chase here without a catalyst: wait for either a macro IT-spend inflection or a cleaner technical base; absent that, the trade is still primarily a valuation repair story, not a fundamental growth re-acceleration.